Healthcare of Ontario Pension Plan Trust Fund Has $758,000 Stock Holdings in Hamilton Lane Incorporated (NASDAQ:HLNE)

Healthcare of Ontario Pension Plan Trust Fund trimmed its stake in Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 70.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,500 shares of the company's stock after selling 10,600 shares during the period. Healthcare of Ontario Pension Plan Trust Fund's holdings in Hamilton Lane were worth $758,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of HLNE. Comerica Bank grew its holdings in shares of Hamilton Lane by 6.3% during the first quarter. Comerica Bank now owns 5,266 shares of the company's stock worth $594,000 after purchasing an additional 311 shares during the last quarter. Cetera Advisors LLC acquired a new stake in shares of Hamilton Lane in the 1st quarter valued at approximately $245,000. Harbor Capital Advisors Inc. boosted its stake in Hamilton Lane by 13.0% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 18,737 shares of the company's stock worth $2,316,000 after acquiring an additional 2,162 shares during the last quarter. SG Americas Securities LLC grew its holdings in Hamilton Lane by 427.0% during the second quarter. SG Americas Securities LLC now owns 25,126 shares of the company's stock valued at $3,105,000 after purchasing an additional 20,358 shares during the period. Finally, Fifth Third Bancorp increased its stake in Hamilton Lane by 106.5% in the second quarter. Fifth Third Bancorp now owns 694 shares of the company's stock valued at $86,000 after purchasing an additional 358 shares in the last quarter. 97.40% of the stock is currently owned by institutional investors and hedge funds.

Hamilton Lane Stock Performance

Hamilton Lane stock traded up $0.04 during midday trading on Tuesday, hitting $191.96. The company's stock had a trading volume of 254,837 shares, compared to its average volume of 313,552. The company has a market cap of $10.64 billion, a price-to-earnings ratio of 41.88 and a beta of 1.19. Hamilton Lane Incorporated has a 1-year low of $97.94 and a 1-year high of $203.72. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.37 and a quick ratio of 3.37. The company has a 50-day moving average price of $182.60 and a two-hundred day moving average price of $151.98.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.06 by $0.01. Hamilton Lane had a net margin of 28.03% and a return on equity of 35.59%. The firm had revenue of $150.00 million for the quarter, compared to the consensus estimate of $151.55 million. During the same period in the prior year, the company posted $0.89 earnings per share. The business's revenue for the quarter was up 18.2% on a year-over-year basis. As a group, sell-side analysts predict that Hamilton Lane Incorporated will post 4.87 earnings per share for the current year.

Hamilton Lane Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 7th. Shareholders of record on Monday, December 16th will be paid a dividend of $0.49 per share. This represents a $1.96 annualized dividend and a yield of 1.02%. The ex-dividend date is Monday, December 16th. Hamilton Lane's payout ratio is presently 42.52%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on HLNE shares. Wells Fargo & Company upped their price objective on shares of Hamilton Lane from $156.00 to $170.00 and gave the company an "equal weight" rating in a research report on Wednesday, October 9th. UBS Group raised their price target on Hamilton Lane from $150.00 to $185.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 22nd. The Goldman Sachs Group boosted their price objective on Hamilton Lane from $139.00 to $147.00 and gave the company a "neutral" rating in a research report on Thursday, October 3rd. JPMorgan Chase & Co. raised their target price on shares of Hamilton Lane from $134.00 to $175.00 and gave the stock a "neutral" rating in a report on Thursday, November 7th. Finally, Morgan Stanley increased their target price on Hamilton Lane from $182.00 to $190.00 and gave the stock an "equal weight" rating in a report on Monday, November 11th. Seven research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $180.33.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.